Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline
20 avr. 2023 08h00 HE
|
Achieve Life Sciences
First Randomized, Placebo-Controlled Clinical Study to Report Successful E-Cigarette Cessation Benefit with Pharmacological Treatment Study Supports Potential Broad Utilization of Cytisinicline for...
U.S. Substance Abuse Treatment Market Report 2023: Surging Rate of Drug Addiction and the Growing Prevalence of Alcohol and Smoking Among Teenagers Drives Growth
17 avr. 2023 07h43 HE
|
Research and Markets
Dublin, April 17, 2023 (GLOBE NEWSWIRE) -- The "Substance Abuse Treatment Market Research Report by Substance Abuse Type (Alcohol Addiction, Cocaine, Marijuana), Product (Behavioral Treatment,...
Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU
14 avr. 2023 07h30 HE
|
Incannex Healthcare
MELBOURNE, Australia, April 14, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal...
‘Tranq,’ or Xylazine Can Worsen the Overdose Crisis Warns Laguna Treatment Hospital
12 avr. 2023 13h27 HE
|
Laguna Treatment Hospital
ALISO VIEJO, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Laguna Treatment Hospital, a leading provider of substance use and co-occurring mental health treatment, is warning residents about the...
Achieve Life Sciences Announces Refresh to Board of Directors
30 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
29 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
$53.87 Billion Smoking Cessation & Nicotine De-Addiction Product Markets - Global Forecast 2023-2030
24 mars 2023 08h43 HE
|
Research and Markets
Dublin, March 24, 2023 (GLOBE NEWSWIRE) -- The "Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product (Drug Therapy, E-Cigarettes, and Nicotine Inhalers),...
Timberline Knolls Offers Yoga Treatment That Incorporates the 12-Step Model
23 mars 2023 11h01 HE
|
Timberline Knolls
Chicago, March 23, 2023 (GLOBE NEWSWIRE) -- Timberline Knolls, a leading treatment center for women and adolescent girls who are struggling with eating disorders, trauma, substance use disorders,...
Local Addiction Retreat Raises Concern Over Illicit Drug Use Ahead of SXSW in Austin, TX
20 mars 2023 09h44 HE
|
Any Length Retreat
AUSTIN, TEXAS, March 20, 2023 (GLOBE NEWSWIRE) -- As thousands make their Spring Break plans, Any Length Retreat, the leading spiritual retreat for treating men’s addiction in Central Texas, wants...
Achieve Life Sciences Announces Granting of New Hire Inducement Award
17 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...